Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Vaxcyte, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Vaxcyte, Inc. held its Annual Meeting of Stockholders on June 15, 2026, where shareholders elected three Class III directors to serve until the 2029 Annual Meeting. This routine governance event reflects the company's commitment to maintaining effective leadership and management continuity.
Key Takeaways
Three Class III director nominees were elected at the Annual Meeting of Stockholders held on June 15, 2026
The elected directors will serve until the 2029 Annual Meeting or until their successors are duly elected
2 more takeaways